Categories: News

Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024

SUNNYVALE, Calif., Oct. 29, 2024 /PRNewswire/ — Ceribell, Inc. (Nasdaq: CBLL) (“Ceribell”), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the third quarter of 2024 after the close of trading on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 7168007. A live and archived webcast of the event will be available in the “Investor Relations” section of the Ceribell website at https://investors.ceribell.com/

About Ceribell Inc.
Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Ceribell System is an AI-powered, rapidly deployable point-of-care electroencephalography (“EEG”) platform designed to address the unmet needs of patients in the acute care setting. The company is headquartered in Sunnyvale, Calif.

Investor Contact
Brian Johnston or Laine Morgan
Gilmartin Group
Investors@ceribell.com

Media Contact
Corrie Rose
Press@ceribell.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ceribell-to-report-third-quarter-2024-financial-results-on-november-12-2024-302290488.html

SOURCE Ceribell, Inc.

Staff

Recent Posts

Javid Javdani Calls for Increased Support for Small Business Owners in California

San Diego Entrepreneur Highlights the Role of International Food Markets in Cultural Exchange and Community…

39 mins ago

3X4 Genetics and Rupa Health Partnership Aims to Bridge the Gap Between Genetic Science and Clinical Practice

SEATTLE, Oct. 31, 2024 /PRNewswire/ -- 3X4 Genetics, a global leader in genetic testing, is…

7 hours ago

Clearwater and Guidehouse Partner to Help Healthcare Organizations Solve Key Cybersecurity Challenges

 Leading Firms to Deliver Solutions Focused on De-Risking M&A and Vendor Partnerships, Leveraging Frameworks, and Optimizing…

7 hours ago

EvaClean and Microsplitting Forge Global Alliance to Revolutionize Cleaning and Disinfection Across Europe, the United Kingdom, and the Middle East

Microsplitting Ltd joins forces with EvaClean Europe to introduce its Infection Prevention System and FlashDry…

7 hours ago

Chobani Taps Industry Veteran Jai Kibe as Chief Marketing Officer

NEW YORK and NEW BERLIN, N.Y., Oct. 31, 2024 /PRNewswire/ -- Chobani, LLC announces the appointment…

7 hours ago

Ampersand Capital Partners Named to Inc.’s 2024 List of Founder-Friendly Investors

BOSTON, Oct. 31, 2024 /PRNewswire/ -- For the third consecutive year, Ampersand Capital Partners has…

7 hours ago